Which of the following is a clinical test to help determine optimal therapeutic use of EGFR inhibitors in lung cancer?
A) EGFR overexpression by immunohistochemistry
B) EGFR activating mutation analysis by PCR
C) EGFR deletion by FISH
D) Chromosome 7 translocation analysis by karyotyping
Correct Answer:
Verified
Q3: Malignant tissue originating in one organ (primary)
Q4: This test is used to determine if
Q5: Which of the following targets is tissue
Q6: Fusions of FKHR and the paired box
Q7: This gene is frequently tested with K-ras
Q9: What are the two checkpoints of the
Q10: Leukemia and lymphoma are:
A) Hematological malignancies
B) Solid
Q11: A patient's diagnosis is ataxia-telangiectasia. The physician
Q12: Mutations in this gene are found in
Q13: These genes form a dimeric enzyme that
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents